•  
  •  
 

Abstract

Depression in patients with cancer influences negatively their physical symptoms, treatment success, coping, and their quality of life, and it is associated with increased mortality. Reported prevalence of emotional distress in patients followed in hematology varies widely across studies. The present study aimed to investigate the prevalence of depression, and to explore the possible associated factors in patients followed in a hematological department Method: in this descriptive cross-sectional study among patients admitted to the hematology department in the University Hospital Mohammed VI of Marrakech, between August 2020 and December 2020, depression symptoms were assessed using Mini International Neuropsychiatric Interview test and Beck Depression Inventory Results: 150 patients participated, regarding their underlying pathology, 60% (90 patients) of patients were newly diagnosed with leukemia, 8% patients were admitted for chronic anemia and 12% for lymphoma. Forty eight percent of them had a characterized depressive episode. Four percent of these episodes were severe, 55% were moderate and 41% were mild. Among all factors analyzed, multivariate analysis showed that high prevalence of depression was associated with female gender and poor prognosis estimation by the patient

Download

Share

COinS